跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确比较工具变量、混杂调整及双重差分相关方法的处理效应估计,直接属于因果推断。

反馈分类问题

Triangulating Instrumental Variable, confounder adjustment and Difference-in-Difference methods for comparative effectiveness research in observational data

观察性比较效果研究中的工具变量、混杂调整与双重差分三角验证

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Laura Güdemann
John M. Dennis
Andrew P. McGovern
Lauren R. Rodgers
William Henley
Jack Bowden

观察性比较效果研究中的工具变量、混杂调整与双重差分三角验证

研究问题
在可能存在未测量混杂的治疗比较中,如何组合依赖不同假设的因果方法,并判断相关联的效应估计是否一致?
方法与思路
作者通过模拟考察多种方法的假设违反,提出利用治疗前后数据的既往结局增强工具变量法,以及考虑估计相关性的异质性统计量。
材料陈述的贡献
摘要称新工具变量方法对关键假设违反具有稳健性,并以糖尿病二线用药与生殖器感染风险的观察数据展示比较框架。
阅读关注点
应核对各方法的效应目标是否相同、所谓稳健性覆盖哪些假设违反,以及异质性统计量如何估计方法之间的相关性。
阅读边界
这是预印本,不能据此确认同行评审或期刊接收;摘要未明确稳健性条件,多个估计相近本身也不能验证其因果假设。

原文摘要

Observational studies can play a useful role in assessing the comparative effectiveness of competing treatments. In a clinical trial the randomization of participants to treatment and control groups generally results in well-balanced groups with respect to possible confounders, which makes the analysis straightforward. However, when analysing observational data, the potential for unmeasured confounding makes comparing treatment effects much more challenging. Causal inference methods such as Instrumental Variable and Prior Even Rate Ratio approaches make it possible to circumvent the need to adjust for confounding factors that have not been measured in the data or measured with error. Direct confounder adjustment via multivariable regression and Propensity score matching also have considerable utility. Each method relies on a different set of assumptions and leverages different aspects of the data. In this paper, we describe the assumptions of each method and assess the impact of violating these assumptions in a simulation study. We propose the prior outcome augmented Instrumental Variable method that leverages data from before and after treatment initiation, and is robust to the violation of key assumptions. Finally, we propose the use of a heterogeneity statistic to decide if two or more estimates are statistically similar, taking into account their correlation. We illustrate our causal framework to assess the risk of genital infection in patients prescribed Sodium-glucose co-transporter-2 inhibitors versus Dipeptidyl peptidase-4 inhibitors as second-line treatment for Type 2 Diabets using observational data from the Clinical Practice Research Datalink.

笔记与分组